Precision Medicine: Progress and Promise

18 de septiembre de 2018 9:00

As genomic technologies move from lab to clinic, how can business and government bridge the gap between availability and access?

Dimensions to be addressed:
- Health system infrastructure
- Data on clinical and cost effectiveness
- Lagging insurance models

This session was developed in partnership with Scientific American.

Simultaneous interpretation in English and Mandarin Chinese

This session will be livestreamed on TopLink and the Forum website.

Oradores:

Elisabet de los Pinos Pont

Founder and Chief Executive Officer, Aura Biosciences Inc.

Mariette DiChristina

Dean, College of Communication, Boston University

Jay Flatley

Digital Member

Wang Jian

President and Co-Founder, BGI